65,437 trials
Myopia
Primary: Subjective Quality of Vision (QoV) — 6.1; 5.3; 4.7 score on a scale
Multiple Sclerosis
Primary: Cerebral Metabolic Rate of Oxygen (CMRO2) — 8.17 micro-mol/100g/min
Memory Consolidation
Primary: Structure Knowledge for a New Modular Category in Stage 2 — 0.563; .5726; .6303; .6266 Proportion of correct responses
Periodontal Diseases
Primary: Change in PD (Periodontal Depth) — 5.63; 5.45; 4.01; 4.03 millimeter
Alcohol Abuse · IPV · Couples
Primary: Heart Rate Variability During Alcohol-Facilitated Intimate Partner Violence (IPV) — 58.60; 62.28; 59.32; 60.15 Milliseconds
Lung Nodule
Primary: Diagnostic Accuracy — 94; 81 Participants — p=0.003
Greater Trochanteric Pain Syndrome · GTPS - Greater Trochanteric Pain Syndrome · Tendon Disorder
Primary: Change in NRS (Numerical Rating Scale) Pain Score From Baseline (Week 0) to Week 10 — 4.7 NRS Pain Score (range 0-10; higher score
Breast Cancer
Primary: LVEF Results — -8; -6 LVEF Percentage (%)
Strabismus
Primary: Comparison of App-measured Eye Deviation Angles to Gold Standard — 3.3 prism diopter
SARS-CoV-2 · COVID-19
Primary: Proportion of Participants With Adverse Reaction (AR) — 1 Participants
Metabolic Diseases
Primary: Collection of Imaging of BAT by Magnetic Resonance Imaging — 78.69; 82.58; 82.45 Percentage
Cigarette Smoking-Related Carcinoma
Primary: Cigarettes Per Day — 14.20; 4.08; 4.55; 14.09 Cigarettes per Day
Alcohol Consumption · Violence, Domestic · Stress, Psychological
Primary: Alcohol Use (Burst 1) — .45; .40; .41; .31 Proportion of reporting days
Pharmacodynamic
Primary: Change in Minute Ventilation — 3.432; 5.744 L/min — p=<0.0009
Prostate Cancer
Primary: Rate of Disease Progression Within the First Two Surveillance Biopsies — 36.1 percentage of participants